Viewing StudyNCT05817214



Ignite Creation Date: 2024-05-06 @ 6:52 PM
Last Modification Date: 2024-10-26 @ 2:56 PM
Study NCT ID: NCT05817214
Status: RECRUITING
Last Update Posted: 2024-04-19
First Post: 2023-04-05

Brief Title: Cadonilimab Plus Anlotinib for RMP Cervical Cancer
Sponsor:
Organization: Zhongnan Hospital